Ukraine Crisis: Gedeon Richter suspends marketing activities in Ukraine
Photo by LaMography / Moni Lazar
Hungarian blue-chip pharma firm Gedeon Richter has told the Budapest Business Journal that it has suspended marketing activities in Ukraine. While operations in Russia are uninterrupted for now, it is too soon to predict the effects of sanctions there.
Responding to a direct approach from budapestbusinessjournal.com, the communications and government relations department of Gedeon Richter Plc. noted that the company “has played an important role in the pharmaceutical supply of Ukraine for decades.”
It employs 200 people in the country, but marketing activities in Ukraine will be suspended “until circumstances once again allow for normal operation,” the company spokesman said.
“As a company listed on the stock exchange, we strictly avoid any speculation regarding the future circumstances. According to our earnings guidance that we shared in our Monday [Feb. 28] press conference, we expect the 2022 revenue in EUR terms to be similar to the 2021 revenue,” the communications department said.
“The higher sales of our specialized products in Western Europe and in the USA could compensate [for] the losses in the CIS markets. However, without the outbreak of the war, the revenue growth could have been in the double digits. The biggest challenge in the current situation is the uncertainty,” the company statement ended.
The Budapest Business Journal is contacting Hungary’s leading companies to gain an understanding of how the war in Ukraine and sanctions against Russia are affecting their business.
SUPPORT THE BUDAPEST BUSINESS JOURNAL
Producing journalism that is worthy of the name is a costly business. For 27 years, the publishers, editors and reporters of the Budapest Business Journal have striven to bring you business news that works, information that you can trust, that is factual, accurate and presented without fear or favor.
Newspaper organizations across the globe have struggled to find a business model that allows them to continue to excel, without compromising their ability to perform. Most recently, some have experimented with the idea of involving their most important stakeholders, their readers.
We would like to offer that same opportunity to our readers. We would like to invite you to help us deliver the quality business journalism you require. Hit our Support the BBJ button and you can choose the how much and how often you send us your contributions.